AdventHealth
Orlando, Florida, 32803, United States
Location status: Recruiting
Location contact
Amanda T Sawyer, PhD
CONTACT
Amanda' T Sawyer, PhD
PRINCIPAL_INVESTIGATOR
Amy West, RN
CONTACT
Nathalie McKenzie, MD
SUB_INVESTIGATOR
NCT Number: NCT07121738
This study will examine the effects of an 8-week intervention called the Healthy Eating Active Lifestyle (HEAL)-GYN program on participants' 1) self-efficacy 2) lifestyle factors, including physical activity and diet, as well as mental health and overall well-being, and 3) biometrics and biomarkers.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Orlando, Florida, 32803, United States
Location status: Recruiting
Amanda T Sawyer, PhD
CONTACT
Amanda' T Sawyer, PhD
PRINCIPAL_INVESTIGATOR
Amy West, RN
CONTACT
Nathalie McKenzie, MD
SUB_INVESTIGATOR
This study will examine the effects of an 8-week intervention called the Healthy Eating Active Lifestyle (HEAL)-GYN program. This telemedicine-based rehabilitation course for patients with gynecologic cancer focuses on lifestyle changes in exercise, nutrition, sleep, social integration, stress management, and avoidance of risk behaviors, such as smoking and alcohol. Led by a certified lifestyle medicine oncologist, the multidisciplinary program includes personalized goal-setting and experiential instruction on these topics. A prospective study will be conducted with up to 64 participants who are patients with gynecologic cancer to examine the effects of the HEAL-GYN program on 1) self-efficacy 2) lifestyle factors, including physical activity and diet, as well as mental health and overall well-being, and 3) biometrics and biomarkers. Participants will complete a survey package at baseline, endpoint, 1-month follow-up, and 3-month follow-up timepoints, which includes the following validated instruments: Weight Efficacy Lifestyle Questionnaire, Godin-Shephard Leisure-Time Physical Activity Questionnaire, Diet History Questionnaire III, Pittsburgh Sleep Quality Index, Body Image Scale, Perceived Stress Scale, Generalized Anxiety Disorder 7-item scale (GAD-7), Patient Health Questionnaire 9-item scale (PHQ-9), and Functional Assessment of Cancer Therapy - General. Objective measurements of physical activity and sleep will be collected using a wearable activity tracker. During home health visits, data related to biometrics will be collected, along with basic lab values and biomarkers of adiponectin, insulin sensitivity, and inflammatory markers through blood samples.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Evidence-based lifestyle medicine program for cancer survivors
Time frame: Baseline, Endpoint (week 8), 1-month follow-up, 3-month follow up
A 20-item questionnaire measuring eating self-efficacy across five domains: negative emotions, availability, social pressure, physical discomfort, and positive activities. Each item is rated on a 10-point scale (0 = Not confident, 9 = Very confident) for the participant's ability to resist overeating in various situations. Higher scores indicate greater confidence in managing eating behaviors (higher eating self-efficacy).
Time frame: Baseline, Endpoint (week 8), 1-month follow-up, 3-month follow up
A 3-item self-report questionnaire asking the number of times per week one engages in strenuous, moderate, and mild leisure exercise. Participants enter frequency counts for each category, which are used to compute a weekly activity score. Higher scores indicate higher physical activity level.
Time frame: Baseline, Endpoint (week 8), 1-month follow-up, 3-month follow up
A ~130-item food frequency questionnaire collecting dietary intake information. Participants report how often they consume various foods and beverages and sometimes portion size. It measures habitual dietary intake and nutrient consumption patterns.
Time frame: Baseline, Endpoint (week 8), 1-month follow-up, 3-month follow up
A 19-item questionnaire assessing habitual sleep quality over the past month in terms of bedtime, sleep latency, duration, efficiency, disturbances, use of sleep aids, and daytime dysfunction. Each item is rated on a 4-point scale (0 = Not during the past month to 3 = ≥3 times/week). A total score is computed (0-21). Higher scores indicate poorer sleep quality.
Time frame: Baseline, Endpoint (week 8), 1-month follow-up, 3-month follow up
A 10-item self-report scale developed for cancer patients to evaluate body image changes. Each item is rated on a 4-point scale (0 = Not at all to 3 = Very much). A total score is computed (0-30). Higher scores indicate greater body image disturbance or dissatisfaction.
Time frame: Baseline, Endpoint (week 8), 1-month follow-up, 3-month follow up
A 10-item scale assessing the degree to which situations in one's life are appraised as stressful. Each item is rated from on a 5-point scale (0 = Never to 4 = Very Often) based on the frequency of feelings in the past month. A total score is computed (0-40). Higher scores indicate higher stress.
Time frame: Baseline, Endpoint (week 8), 1-month follow-up, 3-month follow up
A 7-item screening questionnaire for generalized anxiety. Each item is rated on a 4-point scale (0 = Not at all to 3 = Nearly every day) for how often it occurred over the last 2 weeks. A total score is computed (0-21). Higher totals indicate more severe anxiety symptoms.
Time frame: Baseline, Endpoint (week 8), 1-month follow-up, 3-month follow up
A 9-item depression screening tool. Each item is rated on a 4-point scale (0 = Not at all to 3 = Nearly every day) for how often it occurred over the last 2 weeks. A total score is computed (0-27). Higher totals indicate more severe depressive symptoms.
Time frame: Baseline, Endpoint (week 8), 1-month follow-up, 3-month follow up
A 27-item validated questionnaire measuring health-related quality of life in cancer patients across four domains: physical, social/family, emotional, and functional. Each item is rated on a 5-point scale (0 = Not at all to 4 = Very much). Domain scores are summed to calculate a total score. Higher scores indicate better quality of life.
Time frame: Baseline, 3-month follow up
Participant's standing height, measured in inches using a stadiometer or measuring tape.
Time frame: Baseline, 3-month follow up
Participant's body weight, measured in pounds using a scale
Time frame: Baseline, 3-month follow up
Ratio of waist circumference to hip circumference, both measured in inches using a tape measure.
Time frame: Baseline, 3-month follow up
Comprehensive Metabolic Panel; Blood lipid panel including Low-Density Lipoprotein (LDL), High-Density Lipoprotein (HDL), and triglycerides; Hemoglobin A1c;
Time frame: Baseline, 3-month follow up
A blood biomarker (hormone), measured via blood sample.
Time frame: Baseline, 3-month follow up
An index of how responsive the body is to insulin, measured via blood sample.
Time frame: Baseline, 3-month follow up
Includes C-reactive protein (CRP), Interleukin-6 (IL-6), and Tumor Necrosis Factor-alpha (TNF-α), measured via blood sample.
Time frame: Baseline, Endpoint (week 8), 1-month follow-up, 3-month follow up
Objective measurement of daily minutes spent in light, moderate, and vigorous activity using a wearable activity tracker.
Time frame: Baseline, Endpoint (week 8), 1-month follow-up, 3-month follow up
Objective measurement of nightly minutes spent in light, deep, and REM sleep stages using a wearable activity tracker.
Contact information is provided by the study sponsor or research team.
AdventHealth
Other
Acronym: HEAL-GYN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07735962
Gynecologic Cancers, Infections
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07216456
Anorectal Cancer, Female Urogenital Diseases
Durham, North Carolina, United States
View Trial DetailsNCT07055854
Breast Cancer, Breast Diseases
Corvallis, Oregon, United States
View Trial DetailsNCT07313839
Gynecologic Cancers, Pathologic Processes
Parma, Italy
View Trial Details